+6,105.3%
LRCX vs ABBV
+1,305.4%
+4,800.0%
-57.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ABBV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.8% | -0.9% | -2.9% | -3.5% |
| 7D | -12.9% | -3.7% | -9.2% | -11.7% |
| 30D | -22.7% | -1.9% | -20.8% | -22.1% |
| 3M | -33.6% | +7.3% | -40.9% | -35.4% |
| 6M | -25.4% | +34.4% | -59.8% | -34.2% |
| YTD | +19.3% | +27.8% | -8.5% | +6.6% |
| 1Y | +37.5% | +25.4% | +12.1% | +23.7% |
| 3Y | +198.2% | +126.5% | +71.6% | +105.5% |
| 5Y | +232.5% | +191.3% | +41.1% | +100.6% |
| 10Y | +2,122.3% | +604.1% | +1,518.2% | +823.0% |
| All | +6,105.3% | +1,305.4% | +4,800.0% | +1,900.1% |
Cumulative growth
Daily Returns
Daily percentage return beside ABBV.
Daily Out/Under-Performance
Portfolio return minus ABBV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ABBV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ABBV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling